Chairman of the Board (and CEO)
Didier Hans co-founded Med-Imaps SA in 2006 and became CEO of Medimaps Group in 2012. He currently drives the company’s global strategy, orientation and business objectives, and oversees its Quality Management framework and policies, among many other key tasks.
Based in Switzerland, Didier Hans is also Head of Research and Development in the Bone and Joint Department at the Centre for Bone Diseases at Lausanne University Hospital. He held similar positions in the United States in the Osteoporosis and Arthritis Research Group (OARG) at the University of California San Francisco (UCSF) –; and in France at Lyon University Hospital.
He also co-founded two companies: Synarc, Inc. (US) and Ascendys Sàrl (Switzerland), both of which were successfully sold. He holds a PhD in Medical Physics and an Executive MBA from HEC Geneva.